Using this approach, we aimed to test the hypothesis that activin stimulates ECM remodeling, immunosuppression, and mitogenic signaling in CRC tissue samples in a stage-dependent manner with the goal of targeting activin signaling in advance CRCs. This evidence concerns the gene INHBE and colorectal carcinoma.